Duke University Medical Center has purchased two Sonata MR systems from Siemens Medical Solutions. The two scanners will be dedicated to cardiac MR. Research will focus on myocardial viability imaging. The ultimate goal is to define how MR viability
Duke University Medical Center has purchased two Sonata MR systems from Siemens Medical Solutions. The two scanners will be dedicated to cardiac MR. Research will focus on myocardial viability imaging. The ultimate goal is to define how MR viability studies can fit into general cardiology practices. The deal calls for Siemens to help set up MR training and education courses for clinicians interested in bringing cardiac MR into their practices.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.